Although experimental results suggest that serum CK-BB increase during BPs treatment comes from osteoclasts, no studies have evaluated the course of in vitro release from cultured osteoclasts in healthy donors and possible effects of pathology [7,8,9,10]. The gene discussed is CKB; the disease is Bartsocas-Papas syndrome 1.